Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-

-

 
WKN: A14SDD / Name: Blueprint / Stock / Biotechnology & Medical Research / Mid Cap /

Blueprint Medicines Corp Stock

Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Blueprint Medicines Corp stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Blueprint Medicines Corp in the next few years

Pros
?
C******** o* t** e**********
?
B****
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Blueprint Medicines Corp vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Blueprint Medicines Corp - - - - - - -
Ligand Pharmaceuticals -1.540% -5.970% -8.029% 115.385% 51.807% 309.756% 147.180%
United Therapeutics -0.720% -0.801% -3.900% 78.050% 7.255% 105.978% 195.677%
Ionis Pharmaceuticals Inc. -1.480% -0.275% -33.163% 32.920% -30.547% 30.748% 52.850%

News

Applied Digital Is Building a $36 Billion AI Real Estate EmpirePhoto, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
Applied Digital Is Building a $36 Billion AI Real Estate Empire

Key Points

Webull Q1 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Webull Q1 Earnings Call Highlights

Key Points

Old Money, New Tech: Western Union's Crypto RebootPhoto, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
Old Money, New Tech: Western Union's Crypto Reboot

For years, investors have categorized The Western Union Company (NYSE: WU) as a high-yield value trap, a legacy institution slowly ceding ground to more agile fintech disruptors like Remitly Global